OLR1 and head and neck squamous cell carcinoma: Interestingly, our study showed, for the first time, that the levels of circulating LOX-1+PMN-MDSCs represent an independent prognostic factor of poor prognosis in (R/M) HNSCC patients and a lack of benefit from immunotherapy.